We hypothesize that protein hydrolysate supplementation will attenuate the loss in muscle mass during 7 days of immobilisation and will augment the rate of muscle mass re-gain during recovery.
ID
Bron
Verkorte titel
Aandoening
healthy, young subjects
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
skeletal muscle mass (quadriceps muscle cross sectional area (CSA))
Achtergrond van het onderzoek
Recovery from illness and/or injury often requires a period of physical inactivity. Short periods of inactivity disrupt muscle protein synthesis and breakdown rates, which lead to a loss of skeletal muscle mass. A loss of skeletal muscle mass has been shown to slow recovery and impact quality of life. It is therefore important to develop strategies that can prevent the loss of skeletal muscle mass during periods of inactivity.With the present study, we will investigate whether dietary supplementation with a protein hydrolysate can attenuate skeletal muscle loss following 7 days of one-legged knee immobilisation and augment the rate of muscle mass re-gain during recovery in young men.
Doel van het onderzoek
We hypothesize that protein hydrolysate supplementation will attenuate the loss in muscle mass during 7 days of immobilisation and will augment the rate of muscle mass re-gain during recovery.
Onderzoeksopzet
1 week immobilisation, 2 weeks recovery
Onderzoeksproduct en/of interventie
Subjects will receive a nutritional supplement during immobilisation and recovery. This will be either a protein hydrolysate or a placebo
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1) Male
2) Aged 18-35 y
3) BMI 18.5-30.0 kg/m2
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1) (Family) history of thrombosis
2) (Family) history of Factor V Leiden, or other known thrombophilia (such as; protein C, protein S, antithrombin deficiency)
3) Lower limb, back or shoulder injuries (which may interfere with the use of crutches)
4) Allergies to milk protein
5) Lactose intolerance
6) Participation in structured resistance exercise program
7) All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g., arthritis, spasticity/rigidity, all neurological disorders and paralysis)
8) Any medications known to (or may) affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications)
9) Diagnosed diabetes
10) Diagnosed metabolic, cardiovascular or intestinal disorders
11) A history of neuromuscular problems
12) Use of anti-coagulants
13) Use of protein and/or fish-oil supplements
14) Participation in a 2H2O study in the previous 6 months.
15) Smoking
16) Any recent hospital admission/ major surgery
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL7645 |
| Ander register | METC azM/UM : METC18-073 |